Kilitch Drugs (India) Ltd share price logo

Kilitch Drugs (India) Ltd

NSE: KILITCH

BSE: 524500

Small Cap

Pharma Sector

₹203.78

-15.20

(-6.94%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Kilitch Drugs (India) shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+184%

Searches for Kilitch Drugs (India) on INDmoney have increased by 184% over the last 30 days.

Key Events for Kilitch Drugs (India)

Last Dividend Declared

₹0.50 per share, declared on 30/05/2019

View Dividend History

Kilitch Drugs (India) Stock Performance

as on October 21, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹200.45
    ₹222.00
    downward going graph

    1.63%

    Downside

    8.94%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹117.25
    ₹267.90
    downward going graph

    42.46%

    Downside

    31.47%

    Upside

    downward going graph

Kilitch Drugs (India) share price movements today

Previous Close
₹218.98
Open
₹219.00
Volume
1.39L
Upper Circuit
₹262.77
Lower Circuit
₹175.19
Day's Low - High
₹200.45 - ₹222.00
52 Week Low - High
₹117.25 - ₹267.90

Kilitch Drugs (India) Historical Returns

1 Month Return
+ 8.93 %
3 Month Return
+ 19.97 %
1 Year Return
-41.65 %
3 Year Return
-16.63 %
5 Year Return
+ 34.84 %

Kilitch Drugs (India) Fundamentals

as on October 21, 2026 at 4:01 pm IST

Market Cap

₹765.59 Cr

Return on Equity (ROE)

11.06

PE Ratio (TTM)

24.87

Return on capital employed (ROCE)

12.35

Industry PE ratio

50.28

Beta (LTM)

1.05

P/B Ratio

1.34

Dividend Yield

0

PEG Ratio

88.37

Quarterly Earnings Growth YOY

-12.83

EPS (TTM)

8.44

Book Value

79.99

Kilitch Drugs (India) Stock Valuation

as on October 21, 2026 at 4:01 pm IST

Kilitch Drugs (India) in the last 5 years

  • Overview

  • Trends

Lowest (-986.00x)

July 3, 2019

Today (24.87x)

October 19, 2026

Industry (50.28x)

October 19, 2026

Highest (371.68x)

October 16, 2020

LowHigh

Today’s Price to Earnings Ratio: 24.87x

Kilitch Drugs (India) Technical Analysis

Track how Kilitch Drugs (India) technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish7
Bullish6
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0.27
Bearish
CCI (20)
294.15
Bearish
RSI (14)
48.67
Neutral
Momentum (10)
-1.52
Bullish
ADI (14)
20.11
Neutral
Ultimate Oscillator (7,14,28)
26.62
Bearish

Moving Averages

Name

Value

Action

SMA (20)
204.27
Bearish
EMA (20)
204.3
Bearish
VWMA (20)
204.52
Bearish
SMA (50)
203.69
Bullish
EMA (50)
203.87
Bullish
SMA (200)
203.28
Bullish
EMA (200)
204.36
Bearish
KAMA (200)
203.52
Bullish
DEMA (200)
201.71
Bullish

Kilitch Drugs (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs (India) with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY765.596.97%0.6229235
NA136.993.95%0.0010106
NA17.81-3.54%0.00-246
NA4,596.02363.96%0.61221801
BUY406.4418.95%0.0034168

Market expectation of Kilitch Drugs (India) Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Kilitch Drugs (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
31.79
44.82
33.45
47.47
56.17
61.23
43.14
48.92
53.81
89.6
44.88
Other Income
2.96
0.47
2.57
5.16
1.73
1.7
2.56
6.66
1.53
0.49
2.9
Total Income
34.75
45.29
36.03
52.64
57.89
62.92
45.7
55.58
55.34
90.1
47.78
Expenses
29.51
37.74
31.79
41.38
47.43
46.63
39.88
43.88
47.66
67.46
41.94
Operating Profit
2.28
7.08
1.66
6.09
8.74
14.6
3.26
5.04
6.15
22.14
2.94
Operating Profit Margin %
7.17%
15.8%
4.96%
12.83%
15.56%
23.84%
7.56%
10.3%
11.43%
24.71%
6.55%
Profit Before Interest, Tax and Depreciation
5.24
7.55
4.23
11.26
10.46
16.29
5.82
11.7
7.68
22.64
5.83
Interest
1.6
1.32
1.73
0.31
1.4
1.6
1.53
1.44
1.15
1.44
0.88
Depreciation
0.81
0.93
0.85
0.61
0.81
0.85
0.84
0.86
0.94
0.98
1.09
Profit Before Tax
2.83
5.3
1.65
10.34
8.25
13.84
3.45
9.4
5.59
20.22
3.86
Tax Paid
1.08
1.62
1.54
1.73
2.64
3.63
1.19
1.36
1.28
5.33
1.89
Profit After Tax
1.74
3.68
0.11
8.61
5.61
10.22
2.26
8.04
4.32
14.88
1.97
Total Net profit including share of profit / Loss from associate company
1.74
3.68
0.11
8.61
5.61
10.22
2.26
8.04
4.32
14.88
1.97
EPS
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24
0.83
Actual EPS
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24
0.83
Adjusted EPS
0.91
1.1
0.41
2.62
1.82
3.17
0.92
2.49
1.25
4.24
0.83
Diluted EPS
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24
0.83

Kilitch Drugs (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
51.01
82.49
53.32
68.52
114.23
139.6
154.37
198.32
235.47
Other Income
2.88
4
4.13
2.67
2.91
2.92
4.48
11.16
11.24
Total Income
53.89
86.49
57.45
71.19
117.14
142.52
158.85
209.48
246.71
Expenses
45.73
75.48
53.12
63.33
103.87
122.03
130.22
166.85
198.88
Operating Profit
5.28
7.01
0.2
5.19
10.36
17.57
24.15
31.47
36.59
Operating Profit Margin %
10.35%
8.5%
0.38%
7.57%
9.07%
12.59%
15.64%
15.87%
15.54%
Profit Before Interest, Tax and Depreciation
8.16
11.02
4.32
7.86
13.28
20.48
28.63
42.63
47.84
Interest
-
0.38
0.72
0.75
1.2
4.92
5.93
5.04
5.56
Depreciation
2.04
2.05
2
1.99
2.47
3.55
3.35
3.11
3.62
Profit Before Tax
6.12
8.59
1.6
5.12
9.61
12.01
19.35
34.48
38.66
Tax Paid
0.96
4.76
0.77
1.36
3.4
3.73
5.78
9.53
9.16
Profit After Tax
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
29.5
Total Net profit including share of profit / Loss from associate company
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
29.5
EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91
Actual EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91
Adjusted EPS
1.9
1.28
0.27
1.16
2.31
3.28
4.49
8.12
8.91
Diluted EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91

Kilitch Drugs (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
17.23
1.12
1.42
0.29
4.46
45.66
5.78
2.59
-1.53
17.54
23.96
Cash Flow from Investing Activities
23.49
-1.54
-4.45
-13.98
-10.46
-37.57
-15.25
7.91
-8.15
-39.94
-100.44
Cash Flow from Financing Activities
0.12
-0.04
5.51
16.85
0.85
1.61
7.03
-0.72
8.81
13.25
82.46
Net Cash Flow
-2.23
-0.45
2.48
3.17
-5.14
9.7
-2.44
9.78
-0.88
-9.16
5.97

Kilitch Drugs (India) Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
63.77%
63.77%
63.77%
63.77%
63.77%
DII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.5%
FII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.12%
0.11%
Public
30.77%
30.77%
30.77%
30.76%
30.77%
30.77%
30.76%
36.23%
36.23%
36.22%
36.11%
35.62%
Total Outstanding Shares
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,74,80,782
1,74,80,782
3,49,61,564
3,49,61,564
3,49,61,564
Total Shareholders
9,062
9,525
9,620
9,920
10,139
9,749
10,379
10,929
12,043
11,785
12,627
12,319

Kilitch Drugs (India) Corporate Actions

View detailed summary of the earnings and dividend history of Kilitch Drugs (India).

  • Kilitch Drugs (India) Ltd Earnings Results

    Kilitch Drugs (India) Ltd’s net profit fell -3.96% since last year same period to ₹2.91Cr in the Q1 2026-2027. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -79.96% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Kilitch Drugs (India) Ltd Dividends May,2019

    In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 per share on 30 May 2019 - translating a dividend yield of 0.23%.

    Read More about Dividends

Indices Featuring Kilitch Drugs (India) Stock

Check stock indices that include Kilitch Drugs (India).

BSE Healthcare

₹47,363.53

-401.13 (▲0.84%)

Insights on Kilitch Drugs (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, KILITCH stock has moved up by 52.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 63.77% of holdings in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 470.9% return, outperforming this stock by 487.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Laurus Labs Ltd has given 123.9% return, outperforming this stock by 165.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 36.11% to 35.62% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.12% to 0.11% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 90.1 Cr → 47.78 Cr (in ₹), with an average decrease of 47.0% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 14.52 Cr → 2.91 Cr (in ₹), with an average decrease of 80.0% per quarter

About Kilitch Drugs (India) Ltd

Kilitch Drugs India Ltd (KDIL) is a pharmaceutical company that was incorporated in May 1992 and has since gone public in Feb. 1994. They manufactures a range of pharmaceutical products including tablets, capsules, liquid orals, ointments, creams and injectables. They operate two divisions for OTC and ethical drugs, with additional manufacturing plants located in India, Ethiopia, Republic of Yemen and Patalganga Maharashtra, India. KDIL also provides exports for Sudan, Yemen, the Middle East, Miami and some South American countries. In 2011, they introduced a new product BENIN. In 2012, their undertakings located at Paonta Sahib in Himachal Pradesh were sold and transferred, while certain products were transferred to Akorn India Pvt. Ltd. KDIL's range of pharmaceutical services ensures safe and quality solutions for their customers.

Revenue: ₹44.88Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1.97Cr as on June 2026 (Q1 FY27)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
OrganisationKilitch Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMukund P Mehta
E-voting on sharesClick here to vote

FAQs

What is Kilitch Drugs (India) share price today?

Kilitch Drugs (India) share price today stands at ₹203.78 as on at the close of the market. Kilitch Drugs (India) share today touched a day high of ₹222 and a low of ₹200.45.

What is the 52 week high and 52 week low range for Kilitch Drugs (India) share?

Kilitch Drugs (India) touched a 52 week high of ₹267.9 and a 52 week low of ₹117.25. Kilitch Drugs (India) share price today i.e. is closed at ₹203.78, which is -23.93% down from its 52 week high and 73.80% up from its 52 week low.

What is Kilitch Drugs (India)'s market capitalisation today?

Kilitch Drugs (India) market capitalisation is ₹765.59 Cr as on .

How to buy Kilitch Drugs (India) shares?

To buy Kilitch Drugs (India) shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KILITCH or Kilitch Drugs (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kilitch Drugs (India) shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kilitch Drugs (India) trading volume today?

Kilitch Drugs (India) trading volume is 1.39L as on . This means that 1.39L shares of Kilitch Drugs (India) were bought and sold on the stock market during today's trading session.